Lumicell was awarded several Small Business Innovation Research (SBIR) grants from the National Cancer Institute (NCI) and the National Science Foundation (NSF) that led to the initial scientific discoveries and preliminary work with our academic collaborators. These results have led to several scientific publications. The compelling data from these studies guide Lumicell’s ongoing clinical trials.




  • A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
    Science Translational Medicine 06 Jan 2016: Vol. 8, Issue 320, pp. 320ra4 DOI: 10.1126/scitranslmed.aad0293